A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/535 (2006.01) A61K 31/505 (2006.01)
Patent
CA 2528805
This invention relates to methods of treating or preventing bone loss by administering to a human or animal subject pyrimidine and pyridine derivatives that inhibit the activity of glycogen synthase kinase 3 (GSK3), to pharmaceutical compositions containing the compounds, and to the use of the compounds and compositions alone or in combination with other pharmaceutically active agents.
L'invention concerne des méthodes de traitement ou de prévention de la perte osseuse, consistant à administrer à un patient ou à un animal des dérivés de pyrimidine et de pyridine inhibant l'activité de la glycogène synthase kinase 3 (GSK3), des compositions pharmaceutiques contenant lesdits composés, et l'utilisation desdits composés et compositions seuls ou combinés à d'autres agents actifs d'un point de vue pharmaceutique.
Bennett Christina N.
Hankenson Kurt D.
Harrison Stephen D.
Longo Kenneth A.
Macdougald Ormond A.
Borden Ladner Gervais Llp
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
The Regents Of The University Of Michigan
LandOfFree
Gsk-3 inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gsk-3 inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gsk-3 inhibitors and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1492398